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Background: Hormone replacement therapy (HRT) increases the risk of ischemic stroke in postmenopausal women. The mechanism for this 
remains unclear. It is also known that HRT increases the risk of venous thrombosis. The presence of right-to-left intracardiac shunt (RLS) through a 
patent foramen ovale (PFO) may explain the increased risk of stroke in postmenopausal women on HRT via paradoxical embolism.
Methods: This study is a retrospective analysis of the UCLA, Mayo Clinic, Tufts, and Scripps-Mercy stroke databases. Medical records of 
postmenopausal females with ischemic stroke were assessed for stroke risk factors, HRT and RLS. Modified TOAST (Trial of ORG 10172 in Acute 
Stroke) criteria were used to classify stroke etiology. Those with known shunt and HRT status were included in this analysis. Patients with unknown 
RLS status were offered to undergo transcranial Doppler for shunt detection. The prevalence of HRT use was compared between patients with and 
without RLS within the categories of cryptogenic stroke and stroke of known cause. 
Results:
N= 354 (2251 records reviewed)
Stroke type Total Shunt Status On HRT P value
Known cause 267
RLS+ 50 (18.7%)
RLS- 217 (81.3%)
5*
41
0.13
Cryptogenic 87
RLS+ 55 (63.2%)
RLS- 32 (36.8%)
16*
2
0.01
*Of the 64 women who had a stroke while on HRT, 16/18 (89%) had a PFO in the cryptogenic group compared to 5/46 (11%) in the group with 
stroke of known cause [p=0.0001].
Conclusions: Among the women who were on HRT at the time of the stroke, the presence of a PFO was 8 fold higher in the cryptogenic stroke 
group compared to the group with stroke of known cause. Among the women with cryptogenic strokes, HRT use was 4.7 times more prevalent in 
those with PFO compared to those without PFO. These findings support the hypothesis that the presence of a PFO increases the risk of strokes in 
postmenopausal women who take HRT, presumably via paradoxical embolism.
